Retatrutide 30 mg  –  Retatrutide is a novel triple receptor agonist that targets the GLP-1, GIP, and glucagon receptors, making it a valuable compound for research involving metabolic regulation, energy expenditure, glucose homeostasis, and body composition. Current scientific investigations have focused on its potential effects on body weight reduction, adipose tissue metabolism, appetite regulation, and overall metabolic health in experimental models.

*** FOR RESEARCH PURPOSES ONLY

*** NOT FOR HUMAN CONSUMPTION